A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

NCT02952534 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

277

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Resistant Prostate Cancer

Interventions

DRUG: Rucaparib

Sponsor

pharmaand GmbH

Collaborators

[object Object]